Skip to main content

Table 1 Antibodies used in the present study.

From: Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization

Antibody Type Source Dilution
Vimentin M Dakopatts, Kyoto, Japan 1:50
EMA M Dakopatts 1:50
AE1/AE3 M Dakopatts 1:50
CAM 5.2 M Becton Dickinson, San Jose, CA, USA 1:50
Desmin M Dakopatts 1:50
α-SMA M Dakopatts 1:50
MSA (HHF35) M Enzo Diagnostics, Farmingdale, NY, USA 1:50
S-100 protein P Dakopatts 1:1000
NSE M Dakopatts 1:200
CD68 (KP-1) M Dakopatts 1:200
Lysozyme P Dakopatts 1:500
AAT P Dakopatts 1:1000
ACT P Dakopatts 1:1000
C-Kit P Immuno-Biological Laboratories, Fujioka, Japan 1:10
  1. Abbreviations: EMA, epithelial membrane antigen; α-SMA, alpha-smooth muscle actin; MSA, muscle-specific actin; NSE, neuron-specific enolase; AAT, alpha-1-antitrypsin; ACT, alpha-1-antichymotrypsin; M, monoclonal (mouse); P, polyclonal (rabbit).